Solid-Phase Synthesis and
Siderophore
catechol
hexadentate
iron(III) complexes
structure prediction
synthesis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
12 Oct 2020
12 Oct 2020
Historique:
received:
16
09
2020
revised:
29
09
2020
accepted:
08
10
2020
entrez:
15
10
2020
pubmed:
16
10
2020
medline:
25
2
2021
Statut:
epublish
Résumé
Siderophores are iron-complexing compounds synthesized by bacteria and fungi. They are low molecular weight compounds (500-1500 Daltons) possessing high affinity for iron(III). Since 1970 a large number of siderophores have been characterized, the majority using hydroxamate or catecholate as functional groups. The biosynthesis of siderophores is typically regulated by the iron levels of the environment where the organism is located. Because of their exclusive affinity and specificity for iron(III), natural siderophores and their synthetic derivatives have been exploited in the treatment of human iron-overload diseases, as both diagnostic and therapeutic agents. Here, solid-phase approach for the preparation of hexadentate, peptide-based tricatecholato containing peptides is described. The versatility of the synthetic method allows for the design of a common scaffolding structure whereby diverse ligands can be conjugated. With so many possibilities, a computational approach has been developed which will facilitate the identification of those peptides which are capable of providing a high affinity iron(III) binding site. This study reports an integrated computational/synthetic approach towards a rational development of peptide-based siderophores.
Identifiants
pubmed: 33053658
pii: ijms21207498
doi: 10.3390/ijms21207498
pmc: PMC7593911
pii:
doi:
Substances chimiques
Ferric Compounds
0
Iron Chelating Agents
0
Ligands
0
Siderophores
0
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Parkinson's UK
ID : K-1603
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17164
Pays : United Kingdom
Références
J Pept Res. 2002 Nov;60(5):300-3
pubmed: 12383120
J Inorg Biochem. 2009 Feb;103(2):262-73
pubmed: 19062099
J Chem Theory Comput. 2006 Sep;2(5):1282-90
pubmed: 26626836
Anal Biochem. 1970 Apr;34(2):595-8
pubmed: 5443684
Chem Rev. 2003 Nov;103(11):4207-82
pubmed: 14611263
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Phys Rev Lett. 2003 Oct 3;91(14):146401
pubmed: 14611541
Inorg Chem. 2001 Jul 30;40(16):3922-35
pubmed: 11466050
Org Biomol Chem. 2010 Aug 21;8(16):3665-73
pubmed: 20556294
Nat Prod Rep. 2010 May;27(5):637-57
pubmed: 20376388
Chemistry. 2009 Sep 21;15(37):9394-403
pubmed: 19575348
Inorg Chem. 2004 Dec 27;43(26):8520-5
pubmed: 15606201
FEMS Microbiol Lett. 2014 Jun;355(2):124-30
pubmed: 24813898
Chem Rev. 2018 Aug 22;118(16):7657-7701
pubmed: 30033720
J Cheminform. 2012 Aug 13;4(1):17
pubmed: 22889332
Chem Commun (Camb). 2011 Jul 7;47(25):7068-70
pubmed: 21623436
Analyst. 2015 May 21;140(10):3603-6
pubmed: 25857340